| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.25 | 9e-12 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.29 | 7e-10 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.28 | 5e-07 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 6e-07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-07 |